Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is O-DESMETHYL VENLAFAXINE SUCCINATE MONOHYDRATE USP, with a corresponding US DMF Number 22691.
Remarkably, this DMF maintains an Active status since its submission on March 27, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 29, 2015, and payment made on July 22, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II